NCT07561034 The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
| NCT ID | NCT07561034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Pulmonary Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-07-15 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-07-15 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exercise approach is feasible and associated with improvements in functional performance.
Eligibility Criteria
Inclusion Criteria: * Follows at University of Rochester Medical Center Pulmonary Hypertension Clinic. * Adult patients (\>18 years old) with right heart catheterization confirmed pulmonary hypertension interstitial lung disease on stable therapy dosing for at least 30 days. * Access to a smart phone or email to receive daily messages. * Clinically stable by the investigator. Exclusion Criteria: * Pregnancy. * Pulmonary Hypertension Groups 1,2,4,5. * Resting tachycardia \>120 beats/m during screening. * Inability to walk. * WHO Functional Class IV * Lack of access to email or text messaging. * Participating in a rehabilitation program.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07561034 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07561034 currently recruiting?
Yes, NCT07561034 is actively recruiting participants. Contact the research team at Daniel_Lachant@urmc.rochester.edu for enrollment information.
Where is the NCT07561034 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07561034 clinical trial?
NCT07561034 is sponsored by University of Rochester. The trial plans to enroll 30 participants.